RISS 학술연구정보서비스

검색
다국어 입력

http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

변환된 중국어를 복사하여 사용하시면 됩니다.

예시)
  • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
  • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
닫기
    인기검색어 순위 펼치기

    RISS 인기검색어

      KCI등재 SCOPUS SCIE

      The Relationship between Testosterone Deficiency and Men’s Health

      한글로보기

      https://www.riss.kr/link?id=A104677512

      • 0

        상세조회
      • 0

        다운로드
      서지정보 열기
      • 내보내기
      • 내책장담기
      • 공유하기
      • 오류접수

      부가정보

      다국어 초록 (Multilingual Abstract) kakao i 다국어 번역

      Testosterone is important in the physiology of various organs and tissues. The serum testosterone concentration gradually declines as one of the processes of aging. Thus, the concept of late-onset hypogonadism has gained increasing attention in the last few years. Reported symptoms of late-onset hypogonadism are easily recognized and include diminished sexual desire and erectile quality, particularly in nocturnal erections, changes in mood with concomitant decreases in intellectual activity and spatial orientation, fatigue, depression and anger, a decrease in lean body mass with associated decreases in muscle volume and strength, a decrease in body hair and skin alterations, and decreased bone mineral density resulting in osteoporosis. Among these various symptoms, sexual dysfunction has been the most common and necessary to treat in the field of urology. It is well known that a low serum testosterone level is associated with erectile dysfunction and hypoactive sexual libido and that testosterone replacement treatment can improve these symptoms in patients with hypogonadism. Recently, in addition to sexual dysfunction, a close relationship between metabolic syndrome, characterized by central obesity, insulin resistance, dyslipidemia, and hypertension, and late-onset hypogonadism has been highlighted by several epidemiologic studies. Several randomized control trials have shown that testosterone replacement treatment significantly decreases insulin resistance in addition to its advantage for obesity. Furthermore, metabolic syndrome is one of the major risk factors for cardiovascular disease, and a low serum testosterone level is closely related to the development of atherosclerosis. Presently, it is speculated that a low serum testosterone level may increase the risk for cardiovascular disease. Thus, testosterone is a key molecule in men’s health, especially that of elderly men.
      번역하기

      Testosterone is important in the physiology of various organs and tissues. The serum testosterone concentration gradually declines as one of the processes of aging. Thus, the concept of late-onset hypogonadism has gained increasing attention in the la...

      Testosterone is important in the physiology of various organs and tissues. The serum testosterone concentration gradually declines as one of the processes of aging. Thus, the concept of late-onset hypogonadism has gained increasing attention in the last few years. Reported symptoms of late-onset hypogonadism are easily recognized and include diminished sexual desire and erectile quality, particularly in nocturnal erections, changes in mood with concomitant decreases in intellectual activity and spatial orientation, fatigue, depression and anger, a decrease in lean body mass with associated decreases in muscle volume and strength, a decrease in body hair and skin alterations, and decreased bone mineral density resulting in osteoporosis. Among these various symptoms, sexual dysfunction has been the most common and necessary to treat in the field of urology. It is well known that a low serum testosterone level is associated with erectile dysfunction and hypoactive sexual libido and that testosterone replacement treatment can improve these symptoms in patients with hypogonadism. Recently, in addition to sexual dysfunction, a close relationship between metabolic syndrome, characterized by central obesity, insulin resistance, dyslipidemia, and hypertension, and late-onset hypogonadism has been highlighted by several epidemiologic studies. Several randomized control trials have shown that testosterone replacement treatment significantly decreases insulin resistance in addition to its advantage for obesity. Furthermore, metabolic syndrome is one of the major risk factors for cardiovascular disease, and a low serum testosterone level is closely related to the development of atherosclerosis. Presently, it is speculated that a low serum testosterone level may increase the risk for cardiovascular disease. Thus, testosterone is a key molecule in men’s health, especially that of elderly men.

      더보기

      참고문헌 (Reference)

      1 Namiki M, "Working Committee on Clinical Practice Guidelines for Late-onset Hypogonadism; Japanese Urological Association/Japanese Society for Study of Aging Male. Clinical practice manual for late-onset hypogonadism syndrome" 15 : 377-388, 2008

      2 Seidell JC, "Visceral fat accumulation in men is positively associated with insulin, glucose, and C-peptide levels, but negatively with testosterone levels" 39 : 897-901, 1990

      3 de Tejada IS, "Therapeutic strategies for optimizing PDE-5 inhibitor therapy in patients with erectile dysfunction considered difficult or challenging to treat" 16 (16): S40-S42, 2004

      4 Travison TG, "The relationship between libido and testosterone levels in aging men" 91 : 2509-2513, 2006

      5 Bojesen A, "The metabolic syndrome is frequent in Klinefelter's syndrome and is associated with abdominal obesity and hypogonadism" 29 : 1591-1598, 2006

      6 Jones TH, "The effects of testosterone on risk factors for, and the mediators of, the atherosclerotic process" 207 : 318-327, 2009

      7 Seo SI, "The effects of androgen on penile reflex, erectile response to electrical stimulation and penile NOS activity in the rat" 1 : 169-174, 1999

      8 Traish AM, "The dark side of testosterone deficiency: III. Cardiovascular disease" 30 : 477-494, 2009

      9 Ahn HS, "The clinical relevance of sex hormone levels and sexual activity in the ageing male" 89 : 526-530, 2002

      10 Gades NM, "The associations between serum sex hormones, erectile function, and sex drive: the Olmsted County Study of Urinary Symptoms and Health Status among Men" 5 : 2209-2220, 2008

      1 Namiki M, "Working Committee on Clinical Practice Guidelines for Late-onset Hypogonadism; Japanese Urological Association/Japanese Society for Study of Aging Male. Clinical practice manual for late-onset hypogonadism syndrome" 15 : 377-388, 2008

      2 Seidell JC, "Visceral fat accumulation in men is positively associated with insulin, glucose, and C-peptide levels, but negatively with testosterone levels" 39 : 897-901, 1990

      3 de Tejada IS, "Therapeutic strategies for optimizing PDE-5 inhibitor therapy in patients with erectile dysfunction considered difficult or challenging to treat" 16 (16): S40-S42, 2004

      4 Travison TG, "The relationship between libido and testosterone levels in aging men" 91 : 2509-2513, 2006

      5 Bojesen A, "The metabolic syndrome is frequent in Klinefelter's syndrome and is associated with abdominal obesity and hypogonadism" 29 : 1591-1598, 2006

      6 Jones TH, "The effects of testosterone on risk factors for, and the mediators of, the atherosclerotic process" 207 : 318-327, 2009

      7 Seo SI, "The effects of androgen on penile reflex, erectile response to electrical stimulation and penile NOS activity in the rat" 1 : 169-174, 1999

      8 Traish AM, "The dark side of testosterone deficiency: III. Cardiovascular disease" 30 : 477-494, 2009

      9 Ahn HS, "The clinical relevance of sex hormone levels and sexual activity in the ageing male" 89 : 526-530, 2002

      10 Gades NM, "The associations between serum sex hormones, erectile function, and sex drive: the Olmsted County Study of Urinary Symptoms and Health Status among Men" 5 : 2209-2220, 2008

      11 Stellato RK, "Testosterone, sex hormone-binding globulin, and the development of type 2 diabetes in middle-aged men: prospective results from the Massachusetts male aging study" 23 : 490-494, 2000

      12 Brand JS, "Testosterone, sex hormone-binding globulin and the metabolic syndrome: a systematic review and meta-analysis of observational studies" 40 : 189-207, 2011

      13 Vermeulen A, "Testosterone, body composition and aging" 22 (22): 110-116, 1999

      14 Morales A, "Testosterone supplementation for hypogonadal impotence: assessment of biochemical measures and therapeutic outcomes" 157 : 849-854, 1997

      15 Malkin CJ, "Testosterone replacement in hypogonadal men with angina improves ischaemic threshold and quality of life" 90 : 871-876, 2004

      16 Buvat J, "Testosterone deficiency in men: systematic review and standard operating procedures for diagnosis and treatment" 10 : 245-284, 2013

      17 Laaksonen DE, "Testosterone and sex hormone-binding globulin predict the metabolic syndrome and diabetes in middle-aged men" 27 : 1036-1041, 2004

      18 Liao CH, "Testosterone and sex hormone-binding globulin have significant association with metabolic syndrome in Taiwanese men" 15 : 1-6, 2012

      19 Corona G, "Testosterone and metabolic syndrome: a meta-analysis study" 8 : 272-283, 2011

      20 Jones TH, "TIMES2 Investigators. Testosterone replacement in hypogonadal men with type 2 diabetes and/or metabolic syndrome (the TIMES2 study)" 34 : 828-837, 2011

      21 Morley JE, "Sexuality and disease" 19 : 563-573, 2003

      22 Menke A, "Sex steroid hormone concentrations and risk of death in US men" 171 : 583-592, 2010

      23 Ding EL, "Sex differences of endogenous sex hormones and risk of type 2 diabetes: a systematicreview and meta-analysis" 295 : 1288-1299, 2006

      24 Katabami T, "Serum free testosterone and metabolic syndrome in Japanese men" 57 : 533-539, 2010

      25 Lanfranco F, "Serum adiponectin levels in hypogonadal males: influence of testosterone replacement therapy" 60 : 500-507, 2004

      26 Phillips GB, "Relationship between serum sex hormones and the glucose-insulin-lipid defect in men with obesity" 42 : 116-120, 1993

      27 Foresta C, "Reduced number of circulating endothelial progenitor cells in hypogonadal men" 91 : 4599-4602, 2006

      28 Oh JY, "Rancho Bernardo Study. Endogenous sex hormones and the development of type 2 diabetes in older men and women: the Rancho Bernardo study" 25 : 55-60, 2002

      29 Corona G, "Psychobiologic correlates of the metabolic syndrome and associated sexual dysfunction" 50 : 595-604, 2006

      30 Corona G, "Psycho-biological correlates of hypoactive sexual desire in patients with erectile dysfunction" 16 : 275-281, 2004

      31 Mulligan T, "Prevalence of hypogonadism in males aged at least 45 years: the HIM study" 60 : 762-769, 2006

      32 Baumgartner RN, "Predictors of skeletal muscle mass in elderly men and women" 107 : 123-136, 1999

      33 Abbasi AA, "Predictors of lean body mass and total adipose mass in community-dwelling elderly men and women" 315 : 188-193, 1998

      34 Zumoff B, "Plasma free and non-sex-hormone-binding- globulin-bound testosterone are decreased in obese men in proportion to their degree of obesity" 71 : 929-931, 1990

      35 Haffner SM, "Obesity, body fat distribution and sex hormones in men" 17 : 643-649, 1993

      36 Funahashi T, "Metabolic syndrome: clinical concept and molecular basis" 39 : 482-494, 2007

      37 Lin JW, "Metabolic syndrome, testosterone, and cardiovascular mortality in men" 8 : 2350-2360, 2011

      38 Yassin AA, "Metabolic syndrome, testosterone deficiency and erectile dysfunction never come alone" 40 : 259-264, 2008

      39 Carani C, "Marrama P.Testosterone and erectile function, nocturnal penile tumescence and rigidity, and erectile response to visual erotic stimuli in hypogonadal and eugonadal men" 17 : 647-654, 1992

      40 English KM, "Low-dose transdermal testosterone therapy improves angina threshold in men with chronic stable angina: a randomized, double-blind, placebo-controlled study" 102 : 1906-1911, 2000

      41 Svartberg J, "Low testosterone levels are associated with carotid atherosclerosis in men" 259 : 576-582, 2006

      42 Akishita M, "Low testosterone level is an independent determinant of endothelial dysfunction in men" 30 : 1029-1034, 2007

      43 Akishita M, "Low testosterone level as a predictor of cardiovascular events in Japanese men with coronary risk factors" 210 : 232-236, 2010

      44 Haring R, "Low serum testosterone levels are associated with increased risk of mortality in a population-based cohort of men aged 20-79" 31 : 1494-1501, 2010

      45 Shores MM, "Low serum testosterone and mortality in male veterans" 166 : 1660-1665, 2006

      46 Tsujimura A, "Low serum free testosterone level is associated with carotid intima-media thickness in middle-aged Japanese men" 59 : 809-815, 2012

      47 Haffner SM, "Low levels of sex hormone-binding globulin and testosterone predict the development of non-insulin-dependent diabetes mellitus in men. MRFIT Research Group. Multiple Risk Factor Intervention Trial" 143 : 889-897, 1996

      48 Mathur A, "Long-term benefits of testosterone replacement therapy on angina threshold and atheroma in men" 161 : 443-449, 2009

      49 Torkler S, "Inverse association between total testosterone concentrations, incident hypertension and blood pressure" 14 : 176-182, 2011

      50 Whitsel EA, "Intramuscular testosterone esters and plasma lipids in hypogonadal men: a meta-analysis" 111 : 261-269, 2001

      51 Nieschlag E, "International Society of Andrology (ISA); International Society for the Study of the Aging Male (ISSAM); European Association of Urology (EAU). Investigation, treatment and monitoring of late-onset hypogonadism in males. ISA, ISSAM, and EAU recommendations" 48 : 1-4, 2005

      52 Smith MR, "Insulin sensitivity during combined androgen blockade for prostate cancer" 91 : 1305-1308, 2006

      53 Haffner SM, "Insulin resistance, body fat distribution, and sex hormones in men" 43 : 212-219, 1994

      54 Mäkinen J, "Increased carotid atherosclerosis in andropausal middle-aged men" 45 : 1603-1608, 2005

      55 Hamilton EJ, "Increase in visceral and subcutaneous abdominal fat in men with prostate cancer treated with androgen deprivation therapy" 74 : 377-383, 2011

      56 Yassin AA, "Improvement of sexual function in men with late-onset hypogonadism treated with testosterone only" 4 : 497-501, 2007

      57 Keymel S, "Impaired endothelial progenitor cell function predicts age-dependent carotid intimal thickening" 103 : 582-586, 2008

      58 Corona G, "Hypogonadism as a risk factor for cardiovascular mortality in men: a meta-analytic study" 165 : 687-701, 2011

      59 Ogbera OA, "Hypogonadism and subnormal total testosterone levels in men with type 2 diabetes mellitus" 21 : 517-521, 2011

      60 Beutel ME, "Hypogonadism Investigator Group. Correlations between hormones, physical, and affective parameters in aging urologic outpatients" 47 : 749-755, 2005

      61 Buvat J, "Hypogonadal men nonresponders to the PDE5 inhibitor tadalafil benefit from normalization of testosterone levels with a 1% hydroalcoholic testosterone gel in the treatment of erectile dysfunction (TADTEST study)" 8 : 284-293, 2011

      62 Dhindsa S, "Frequent occurrence of hypogonadotropic hypogonadism in type 2 diabetes" 89 : 5462-5468, 2004

      63 De Pergola G, "Free testosterone plasma levels are negatively associated with the intima-media thickness of the common carotid artery in overweight and obese glucose- tolerant young adult men" 27 : 803-807, 2003

      64 Heufelder AE, "Fifty-two-week treatment with diet and exercise plus transdermal testosterone reverses the metabolic syndrome and improves glycemic control in men with newly diagnosed type 2 diabetes and subnormal plasma testosterone" 30 : 726-733, 2009

      65 Khaw KT, "Endogenous testosterone and mortality due to all causes, cardiovascular disease, and cancer in men: European prospective investigation into cancer in Norfolk (EPIC-Norfolk) Prospective Population Study" 116 : 2694-2701, 2007

      66 Ruige JB, "Endogenous testosterone and cardiovascular disease in healthy men: a meta-analysis" 97 : 870-875, 2011

      67 Mäkinen JI, "Endogenous testosterone and brachial artery endothelial function in middle-aged men with symptoms of late-onset hypogonadism" 14 : 237-242, 2011

      68 Muller M, "Endogenous sex hormones and progression of carotid atherosclerosis in elderly men" 109 : 2074-2079, 2004

      69 Muller M, "Endogenous sex hormones and metabolic syndrome in aging men" 90 : 2618-2623, 2005

      70 van den Beld AW, "Endogenous hormones and carotid atherosclerosis in elderly men" 157 : 25-31, 2003

      71 Bancroft J, "Endocrinology of sexual function" 7 : 253-281, 1980

      72 Morales A, "Endocrine aspects of sexual dysfunction in men" 1 : 69-81, 2004

      73 Buvat J, "Endocrine aspects of male sexual dysfunctions" 7 : 1627-1656, 2010

      74 Aversa A, "Effects of testosterone undecanoate on cardiovascular risk factors and atherosclerosis in middle- aged men with late-onset hypogonadism and metabolic syndrome: results from a 24-month, randomized, doubleblind, placebo-controlled study" 7 : 3495-3503, 2010

      75 Kalinchenko SY, "Effects of testosterone supplementation on markers of the metabolic syndrome and inflammation in hypogonadal men with the metabolic syndrome: the double- blinded placebo-controlled Moscow study" 73 : 602-612, 2010

      76 Isidori AM, "Effects of testosterone on sexual function in men: results of a meta-analysis" 63 : 381-394, 2005

      77 Webb CM, "Effects of testosterone on coronary vasomotor regulation in men with coronary heart disease" 100 : 1690-1696, 1999

      78 Haidar A, "Effects of androgen deprivation on glycaemic control and on cardiovascular biochemical risk factors in men with advanced prostate cancer with diabetes" 10 : 189-196, 2007

      79 Pasquali R, "Effect of obesity and body fat distribution on sex hormones and insulin in men" 40 : 101-104, 1991

      80 Wu FC, "EMAS Group. Identification of late-onset hypogonadism in middle-aged and elderly men" 363 : 123-135, 2010

      81 Tajar A, "EMAS Group. Characteristics of androgen deficiency in late-onset hypogonadism: results from the European Male Aging Study (EMAS)" 97 : 1508-1516, 2012

      82 Corona G, "Different testosterone levels are associated with ejaculatory dysfunction" 5 : 1991-1998, 2008

      83 Hwang TI, "Combined use of androgen and sildenafil for hypogonadal patients unresponsive to sildenafil alone" 18 : 400-404, 2006

      84 Kapoor D, "Clinical and biochemical assessment of hypogonadism in men with type 2 diabetes: correlations with bioavailable testosterone and visceral adiposity" 30 : 911-917, 2007

      85 Smith MR, "Changes in body composition during androgen deprivation therapy for prostate cancer" 87 : 599-603, 2002

      86 Tsujimura A, "Bioavailable testosterone with age and erectile dysfunction" 170 : 2345-2347, 2003

      87 Empen K, "Association of testosterone levels with endothelial function in men: results from a population-based study" 32 : 481-486, 2012

      88 Zitzmann M, "Association of specific symptoms and metabolic risks with serum testosterone in older men" 91 : 4335-4343, 2006

      89 Akishita M, "Association of low testosterone with metabolic syndrome and its components in middle-aged Japanese men" 33 : 587-591, 2010

      90 Fukui M, "Association between serum testosterone concentration and carotid atherosclerosis in men with type 2 diabetes" 26 : 1869-1873, 2003

      91 Morales A, "Andropause: a misnomer for a true clinical entity" 163 : 705-712, 2000

      92 Vermeulen A, "Andropause" 34 : 5-15, 2000

      93 Reilly CM, "Androgens modulate the alpha-adrenergic responsiveness of vascular smooth muscle in the corpus cavernosum" 18 : 26-31, 1997

      94 Nishizawa H, "Androgens decrease plasma adiponectin, an insulin-sensitizing adipocyte-derived protein" 51 : 2734-2741, 2002

      95 Mills TM, "Androgens and penile erection: a review" 17 : 633-638, 1996

      96 Morley JE, "Androgens and aging" 38 : 61-71, 2001

      97 Mårin P, "Androgen treatment of abdominally obese men" 1 : 245-251, 1993

      98 Mills TM, "Androgen maintenance of erectile function in the rat penis" 46 : 342-348, 1992

      99 Morley JE, "Androgen deficiency in aging men" 83 : 1279-1289, 1999

      100 Goldstein BJ, "Adiponectin: a novel adipokine linking adipocytes and vascular function" 89 : 2563-2568, 2004

      101 Ryo M, "Adiponectin as a biomarker of the metabolic syndrome" 68 : 975-981, 2004

      102 Tsujimura A, "Adiponectin and testosterone in patients with symptoms of late-onset hypogonadism: is there a link?" 16 : 830-835, 2009

      더보기

      동일학술지(권/호) 다른 논문

      동일학술지 더보기

      더보기

      분석정보

      View

      상세정보조회

      0

      Usage

      원문다운로드

      0

      대출신청

      0

      복사신청

      0

      EDDS신청

      0

      동일 주제 내 활용도 TOP

      더보기

      주제

      연도별 연구동향

      연도별 활용동향

      연관논문

      연구자 네트워크맵

      공동연구자 (7)

      유사연구자 (20) 활용도상위20명

      인용정보 인용지수 설명보기

      학술지 이력

      학술지 이력
      연월일 이력구분 이력상세 등재구분
      2023 평가예정 해외DB학술지평가 신청대상 (해외등재 학술지 평가)
      2020-01-01 평가 등재학술지 유지 (해외등재 학술지 평가) KCI등재
      2017-09-01 평가 SCIE 등재 (기타) KCI등재
      2016-01-01 평가 등재학술지 유지 (계속평가) KCI등재
      2012-11-23 학술지명변경 한글명 : 대한남성과학회지 -> The World Journal of Men's Health
      외국어명 : The Korean Journal of Andrology -> The World Journal of Men's Health
      KCI등재
      2012-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2009-01-01 평가 등재학술지 선정 (등재후보2차) KCI등재
      2008-01-01 평가 등재후보 1차 PASS (등재후보1차) KCI등재후보
      2007-01-01 평가 등재후보학술지 유지 (등재후보2차) KCI등재후보
      2006-01-01 평가 등재후보 1차 PASS (등재후보1차) KCI등재후보
      2004-01-01 평가 등재후보학술지 선정 (신규평가) KCI등재후보
      더보기

      학술지 인용정보

      학술지 인용정보
      기준연도 WOS-KCI 통합IF(2년) KCIF(2년) KCIF(3년)
      2016 0.15 0.15 0.18
      KCIF(4년) KCIF(5년) 중심성지수(3년) 즉시성지수
      0.17 0.14 0.457 0.04
      더보기

      이 자료와 함께 이용한 RISS 자료

      나만을 위한 추천자료

      해외이동버튼